Compare Boston Scientific Corporation (BSX) vs Godaddy Inc (GDDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Godaddy Inc — how do they compare? Boston Scientific Corporation trades at $43.28 (market cap $66.37B), while Godaddy Inc trades at $91.11 (market cap $12.06B). The key difference: Boston Scientific Corporation is far larger — about 5.5× Godaddy Inc's market cap, and Godaddy Inc is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | GDDY | |
|---|---|---|
Market Cap | $66.37B | $12.06B |
Sector | Health | Technology |
52-Week High | $108.14 | $169.40 |
52-Week Low | $42.63 | $75.07 |
Enterprise Value | $75.94B | $14.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
GoDaddy (GDDY) trades at $90.86, up 2.18% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company shows robust fundamentals, including a 17.32% net income margin and a P/E of 14.4, while analyst consensus is a Buy with a $123 price target. However, recent news highlights a securities class action investigation, adding a layer of risk.
The outlook remains positive due to consistent earnings performance and solid cash flow, but investors should weigh the legal overhang and high debt levels against the stock's growth potential and attractive valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →
